Latest News
Researchers at the Yale School of Public Health estimate that the United States could reduce its annual spending on outpatient prescription drugs by $184 billion—a 51% decrease—if domestic prices were aligned with those in other high-income nations.
- December 19, 2025
A new report from the Yale School of Public Health warns that the U.S. government’s abrupt cancellation of funding for mRNA vaccine research could have devastating health and economic consequences for the nation.
- October 14, 2025Source: CT Public Radio
A Yale School of Public Health-Penn study frequently cited by members of Congress warns that a proposal to cut Affordable Care Act subsidies could cost 50,000 American lives each year. YSPH Professor Alison P. Galvani, one of the study's authors, discusses the findings with Connecticut Public Radio.
- June 03, 2025
Public health and policy researchers at Yale University and the University of Pennsylvania say that proposed changes to Medicaid and other U.S. health programs could lead to more than 51,000 deaths annually if enacted.
- November 01, 2024Source: CT Public Radio
Newer medications to treat diabetes and obesity are saving lives, but those who need the injectable drugs the most, were the least likely to get them.
- October 16, 2024
Expanding access to weight-loss medications could prevent more than 40,000 deaths a year in the United States, according to a 2024 study led by researchers at Yale School of Public Health and the University of Florida.
- April 22, 2024Source: Yale News
Proposed changes to Medicare and Medicaid, including raising the age of Medicare eligibility, could lead to thousands of additional deaths, a Yale study shows.
- March 25, 2024Source: Healio
An annual COVID-19 vaccination campaign, in which second doses were administered to certain at-risk populations, was associated with reduced disease burden and health care costs, according to a new study led by researchers at the Yale School of Public Health.
- January 02, 2024
Respiratory syncytial virus (RSV) vaccines recently approved for people 60 and older would dramatically reduce the disease’s significant burden of illness and death in the United States if they were widely adopted like annual influenza vaccines, a new study has found.
- July 05, 2023Source: The Commonwealth Fund
The COVID-19 pandemic has underscored the public health and economic vulnerabilities of the United States. As the public health emergency ends, it’s important to reflect on what we’ve learned, consider the persistent risk posed by emerging diseases, and identify steps to mitigate future pandemic threats.